+499.5%
MRNA vs LHX
-4.7%
+504.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LHX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.2% | -0.1% | -1.5% |
| 7D | +5.5% | -2.4% | +7.9% | +6.3% |
| 30D | +158.7% | -10.4% | +169.1% | +168.1% |
| 3M | +182.1% | -16.9% | +199.0% | +202.9% |
| 6M | +151.8% | -29.9% | +181.7% | +202.6% |
| YTD | +393.6% | -12.0% | +405.5% | +411.4% |
| 1Y | +499.5% | -4.5% | +504.0% | +529.1% |
| All | +499.5% | -4.7% | +504.1% | +529.1% |
Cumulative growth
Daily Returns
Daily percentage return beside LHX.
Daily Out/Under-Performance
Portfolio return minus LHX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LHX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LHX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling